Smithson Pharmaceuticals India Private Limited
About Smithson Pharmaceuticals India Private Limited
Data last updated:
Smithson Pharmaceuticals India Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2015PTC034163. Its GSTIN is 23AAWCS3138E1Z9 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Smita Shrivastava and Sunil Mujawadiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 13 Sampat Hills Bicholi Mardana, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.93 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹7,590 (net margin -1.1%) and EBITDA of ₹1,493 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 13 Sampat Hills Bicholi Mardana, Indore, Madhya Pradesh, India – 452001
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Smithson Pharmaceuticals India Private Limited
The main business activity of Smithson Pharmaceuticals India is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Smithson Pharmaceuticals India Private Limited FY 2025 filings available
Smithson Pharmaceuticals India Private Limited reported revenue of ₹6.93 Lakh (down 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Smithson Pharmaceuticals India Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 14% fall in the latest year. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Smithson Pharmaceuticals India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1,493 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7,590 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Smithson Pharmaceuticals India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Smithson Pharmaceuticals India are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Shrivastava | Director | 05 May 2015 | 11 Years 5 Months | Current |
| Sunil Mujawadiya | Director | 05 May 2015 | 11 Years 5 Months | Current |
Peer Comparison of Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saniance Pharmaceuticals Private Limited | ₹7 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Bangalore, Karnataka, India |
| Vanin Pharmaceuticals Private Limited | ₹6.99 Lakh (FY 2024) | •••• | •••• | •••• | Vejalpur, Gujarat, India | |
| Rxsum Pharmaceuticals Private Limited | ₹6.98 Lakh (FY 2017) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Admit Pharmaceuticals Private Limited | ₹6.97 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Ahmedabad, Gujarat, India |
| Welcure Pharmaceuticals Private Limited | ₹6.93 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | New Delhi, Delhi, India |
| Smithson Pharmaceuticals India Private Limited this company | ₹6.93 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Indore, Madhya Pradesh, India |
| Eravic Pharmaceuticals Private Limited | ₹6.91 Lakh (FY 2021) | •••• | •••• | 111.0% | •••• | Lucknow, Uttar Pradesh, India |
| Asdr India Pharmaceuticals Private Limited | ₹6.9 Lakh (FY 2019) | •••• | •••• | -42.0% | •••• | Dehradun, Uttarakhand, India |
| Protek Pharmaceuticals Private Limited | ₹6.88 Lakh (FY 2023) | •••• | •••• | 16.0% | •••• | Patna, Bihar, India |
| Martin and Harris Pharmaceuticals Private Limited | ₹6.87 Lakh (FY 2022) | •••• | •••• | 15.0% | •••• | Mohali, Punjab, India |
| Anormed Pharmaceuticals Private Limited | ₹6.86 Lakh (FY 2024) | •••• | •••• | 520.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Smithson Pharmaceuticals India by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Smithson Pharmaceuticals India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Smithson Pharmaceuticals India Private Limited
Employment history and EPFO contributions of people linked to Smithson Pharmaceuticals India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Smita Shrivastava was appointed as Director on 05 May 2015.
Credit Ratings, Litigation & Regulatory Alerts for Smithson Pharmaceuticals India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Smithson Pharmaceuticals India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Smithson Pharmaceuticals India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAWCS3138E1Z9 | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Smithson Pharmaceuticals India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Smithson Pharmaceuticals India Private Limited
Smithson Pharmaceuticals India is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 05 May 2015 (11+ years old) and is registered under CIN U24230MP2015PTC034163.
Smithson Pharmaceuticals India reported revenue of ₹6.93 Lakh for FY 2024 (down 14% YoY).
Smithson Pharmaceuticals India has 2 current directors:
- Smita Shrivastava - Director
- Sunil Mujawadiya - Director
Smithson Pharmaceuticals India reported a net loss of ₹7,590 (net margin -1.1%) and EBITDA of ₹1,493 (EBITDA margin 0.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Smithson Pharmaceuticals India is 6% over three years and -10% over five years. In the latest year (FY 2024) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Smithson Pharmaceuticals India is 23AAWCS3138E1Z9, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Smithson Pharmaceuticals India is U24230MP2015PTC034163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smithson Pharmaceuticals India was incorporated on 05 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Smithson Pharmaceuticals India by revenue are Saniance Pharmaceuticals Private Limited, Vanin Pharmaceuticals Private Limited, Rxsum Pharmaceuticals Private Limited, Admit Pharmaceuticals Private Limited, Welcure Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Smita Shrivastava was appointed as Director on 05 May 2015. Sunil Mujawadiya was appointed as Director on 05 May 2015.
The registered office of Smithson Pharmaceuticals India is at D – 13 Sampat Hills Bicholi Mardana, Indore, Madhya Pradesh, India – 452001.